White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues
- PMID: 8560972
- DOI: 10.1007/BF00294800
White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues
Abstract
Membrane-type matrix metalloprotease (MT-MMP) is an activator of gelatinase A (MMP-2), which has previously been found in carcinoma cells. We examined non-neurological and Alzheimer's disease brain tissues for MT-MMP by immunohistochemistry and in situ hybridization. The anti-MT-MMP antibodies gave positive staining of brain microglial cells in all the brain tissues. Positively stained microglia were found only in the white matter. The cells producing MT-MMP protein were also shown to be white matter microglia. These results provide further evidence that activated gelatinase A, which may be a processing enzyme for degradation of beta-amyloid protein, may be produced in white matter microglia.
Similar articles
-
Selective localization of gelatinase A, an enzyme degrading beta-amyloid protein, in white matter microglia and in Schwann cells.Acta Neuropathol. 1995;89(3):199-203. doi: 10.1007/BF00309334. Acta Neuropathol. 1995. PMID: 7538720
-
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.Cancer Res. 1996 Jan 15;56(2):384-92. Cancer Res. 1996. PMID: 8542596
-
Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues.Acta Neuropathol. 1998 Oct;96(4):347-50. doi: 10.1007/s004010050904. Acta Neuropathol. 1998. PMID: 9796998
-
Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.J Biochem. 1996 Feb;119(2):209-15. doi: 10.1093/oxfordjournals.jbchem.a021223. J Biochem. 1996. PMID: 8882706 Review.
-
Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.Thromb Haemost. 1997 Jul;78(1):497-500. Thromb Haemost. 1997. PMID: 9198203 Review.
Cited by
-
CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.J Neuroimmunol. 2010 Jul 27;224(1-2):108-13. doi: 10.1016/j.jneuroim.2010.05.002. J Neuroimmunol. 2010. PMID: 20554030 Free PMC article.
-
Heart failure alters matrix metalloproteinase gene expression and activity in rat skeletal muscle.Int J Exp Pathol. 2006 Dec;87(6):437-43. doi: 10.1111/j.1365-2613.2006.00497.x. Int J Exp Pathol. 2006. PMID: 17222211 Free PMC article.
-
Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial.Nat Med. 2025 Apr;31(4):1257-1266. doi: 10.1038/s41591-025-03559-0. Epub 2025 Mar 10. Nat Med. 2025. PMID: 40065171 Free PMC article. Clinical Trial.
-
Extracellular matrix degradation by metalloproteinases and central nervous system diseases.Mol Neurobiol. 1999 Jun;19(3):267-84. doi: 10.1007/BF02821717. Mol Neurobiol. 1999. PMID: 10495107 Review.
-
Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12530-5. doi: 10.1073/pnas.0804273106. Epub 2009 Jul 15. Proc Natl Acad Sci U S A. 2009. PMID: 19617536 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous